INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

10,692 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
37
KS
Kumar Vinay S.Chief Product & Tech Officer
DOCNDigitalOcean Holdings, Inc.
Tax withholding
F$2.50M
16.7K sh
Jun 30, 2026Sep 3, 2026
Page 57 of 268
← PrevNext →
traded Jun 30, 2026
+65d
SEC Form 4

Evidence

37
JP
Jenisch Jan PhilippDirector, Chairman & CEO
AMRZAmrize Ltd
Open-market purchase
BUY$42K
1,000 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

36
HH
Hooijer HenrietteDirector, Chief Financial Officer
DRDDRDGOLD LTD
Open-market sale
SELL$23K
8,313 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

35
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$128K
6,675 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

35
RA
Renner AlexandraChief Product Officer
OKLOOklo Inc.
Open-market sale
SELL$74K
1,930 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

35
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$84K
4,375 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

35
RJ
Russell Steven JonChief Medical Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$81K
4,221 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

35
JP
Jackson Jeremy PeterDirector, Chief Executive Officer
FLUTFlutter Entertainment plc
Open-market sale
SELL$172K
1,762 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

35
CR
Coldrake RobertChief Financial Officer
FLUTFlutter Entertainment plc
Open-market sale
SELL$69K
710 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

34
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$5.31M
166.5K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

34
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
33.5K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

32
HM
Hopman MarkChief Commercial Officer
BBNXBeta Bionics, Inc.
Open-market sale
SELL$102K
5,327 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

32
PS
Pariaros SymeonChief Administrative Officer
ESEAEUROSEAS LTD.
Open-market sale
SELL$75K
950 sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

31
NC
Nueno CarlosPresident, International
TDOCTeladoc Health, Inc.
Open-market sale
SELL$39K
6,200 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

31
SJ
Schoeman JacobusChief Operating Officer
DRDDRDGOLD LTD
Option exercise
M—
19.4K sh
Aug 13, 2026Sep 3, 2026
traded Aug 13, 2026
+21dSEC Form 4

Evidence

31
GH
Gouws HenryHead of Prod., Dir. of Ergo
DRDDRDGOLD LTD
Option exercise
M—
16.8K sh
Aug 13, 2026Sep 3, 2026
traded Aug 13, 2026
+21dSEC Form 4

Evidence

31
SR
Stone Michael RobertDirector
BETABETA Technologies, Inc.
Open-market purchase
BUY$251K
12.8K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

31
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale
SELL$46K
7,357 sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

31
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
16.1K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

31
SR
Stone Michael RobertDirector
BETABETA Technologies, Inc.
Open-market purchase
BUY$252K
13.1K sh
Sep 2, 2026Sep 3, 2026
traded Sep 2, 2026
+1dSEC Form 4

Evidence

30
RS
Rslgh, Llc10% Owner
RYMRYTHM, Inc.
Option exercise
M$1.35M
57.4K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

30
RS
Rslgh, Llc10% Owner
RYMRYTHM, Inc.
Option exercise
M$2.25M
76.3K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC Form 4

Evidence

49
Sheldon WhitehouseDSelf
NVDANVIDIA CORP
sell
SELL$15K – $50KAug 13, 2026Sep 2, 2026
traded Aug 13, 2026
+20dSenate PTR

Evidence

46
KH
Karp Jason H.Director
GROVGrove Collaborative Holdings, Inc.
Open-market purchase
BUY$57K
55.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

46
YM
Yurcisin Jeffrey MichaelDirector, President & CEO
GROVGrove Collaborative Holdings, Inc.
Open-market purchase
BUY$95K
90.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

45
Sheldon WhitehouseDSpouse
NVDANVIDIA CORP
sell
SELL$1,001 – $15KAug 13, 2026Sep 2, 2026
traded Aug 13, 2026
+20dSenate PTR

Evidence

42
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$1.55M
40.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

42
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$1.54M
40.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

42
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$1.55M
40.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

42
LC
Liu ChiDirector, Chief Executive Officer
ATHMAutohome Inc.
Open-market sale
SELL$132K
23.8K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

42
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$1.54M
40.0K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

40
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Open-market purchase
BUY$11K
1,500 sh
Aug 28, 2026Sep 2, 2026
traded Aug 28, 2026
+5dSEC Form 4

Evidence

40
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$723K
403.6K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

40
Sheldon WhitehouseDSpouse
LRCXLAM RESEARCH CORP
sell
SELL$1,001 – $15KAug 13, 2026Sep 2, 2026
traded Aug 13, 2026
+20dSenate PTR

Evidence

40
John J. McGuire IIIRSpouse
NVDANVIDIA CORP
Purchase
BUY$1,001 – $15KAug 18, 2026Sep 2, 2026
traded Aug 18, 2026
+15dHouse PTR

Evidence

39
ZS
Zhou ShengleiDirector
ATHMAutohome Inc.
Open-market sale
SELL$36K
6,548 sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC Form 4

Evidence

37
John J. McGuire IIIRSpouse
AAPLApple Inc.
Partial sale
SELL$1,001 – $15KAug 18, 2026Sep 2, 2026
traded Aug 18, 2026
+15dHouse PTR

Evidence

36
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$322K
179.1K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC Form 4

Evidence

36
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$338K
187.7K sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence

36
JD
John Angela DDirector
TTITETRA TECHNOLOGIES INC
Open-market purchase
BUY$65K
10.0K sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC Form 4

Evidence